Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial.

Pircher, M, Mlineritsch, B, Fridrik, MA, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Rinnerthaler, G, Ressler, S, Ulmer, H, Greil, R.

http://www.ncbi.nlm.nih.gov/pubmed/25550597